Pharmacotherapeutic targeting of cation‐chloride cotransporters in neonatal seizures
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Summary: Seizures are a common manifestation of acute neurologic insults in neonates and are often resistant to the standard antiepileptic drugs that are efficacious in children and adults. The paucity of evidence‐based treatment guidelines, coupled with a rudimentary understanding of disease pathogenesis, has made the current treatment of neonatal seizures empiric and often ineffective, highlighting the need for novel therapies. Key developmental differences in γ‐aminobutyric acid (GABA)ergic neurotransmission between the immature and mature brain, and trauma‐induced alterations in the function of the cation‐chloride cotransporters (CCC s) NKCC 1 and KCC 2, probably contribute to the poor efficacy of standard antiepileptic drugs used in the treatment of neonatal seizures. Although CCC s are attractive drug targets, bumetanide and other existing CCC inhibitors are suboptimal because of pharmacokinetic constraints and lack of target specificity. Newer approaches including isoform‐specific NKCC 1 inhibitors with increased central nervous system penetration, and direct and indirect strategies to enhance KCC 2‐mediated neuronal chloride extrusion, might allow therapeutic modulation of the GABA ergic system for neonatal seizure treatment. A PowerPoint slide summarizing this article is available for download in the Supporting Information section here.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185 · cited 1×
“A crucial part of CNS drug development is the assessment of the bioavailability of a candidate compound in the brain; and the ability of a compound to penetrate the BBB is often a major limiting factor.(72) Only the unbound and nonionized (uncharged) form of bumetanide (or any other weak acid) is able to diffuse acros…”
BackgroundThe K+/Cl− co-transporter KCC2 renders GABA hyperpolarizing during neuronal maturation
Rivera, C., Voipio, J., Payne, J. A., Ruusuvuori, E., Lahtinen, H., Lamsa, K., Pirvola, U., Saarma, M., & Kaila, K. (1999) · Nature · doi:10.1038/16697 · Cited by 2,152 · cited 3×
“During neuronal maturation, the expression and functionality of KCC2 are progressively increased, which sets the basis for the generation of classical hyperpolarizing inhibitory postsynaptic potentials (IPSPs).(16) The efficacy of hyperpolarizing IPSPs is determined by the number of open GABAARs and functionality of C…”
BackgroundSelf-citationSpatio-temporal transcriptome of the human brain
Kang, H. J., Kawasawa, Y. I., Cheng, F., Zhu, Y., Xu, X., Li, M., Sousa, A. M. M., Pletikos, M., Meyer, K. A., Sedmak, G., et al. (2011) · Nature · doi:10.1038/nature10523 · Cited by 2,084
Translating developmental time across mammalian species
Clancy, B., Darlington, R. B., & Finlay, B. L. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00171-3 · Cited by 1,221
Yamada, J., Okabe, A., Toyoda, H., Kilb, W., Luhmann, H. J., & Fukuda, A. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.062471 · Cited by 572
Sarkar, J., Wakefield, S., MacKenzie, G., Moss, S. J., & Maguire, J. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.2560-11.2011 · Cited by 254
Vanhatalo, S., Palva, J. M., Andersson, S., Rivera, C., Voipio, J., & Kaila, K. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04459.x · Cited by 230
Foroutan, S., Brillault, J., Forbush, B., & O’Donnell, M. E. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00257.2005 · Cited by 81
Cited by
Löscher, W., Potschka, H., Sisodiya, S. M., & Vezzani, A. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019539 · Cited by 903
Cation-chloride cotransporters in neuronal development, plasticity and disease
Kaila, K., Price, T. J., Payne, J. A., Puskarjov, M., & Voipio, J. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3819 · Cited by 749
Self-citationDeidda, G., Parrini, M., Naskar, S., Bozarth, I. F., Contestabile, A., & Cancedda, L. (2015) · Nature Medicine · doi:10.1038/nm.3827 · Cited by 268
Treatment during a vulnerable developmental period rescues a genetic epilepsy
Marguet, S. L., Le-Schulte, V. T. Q., Merseburg, A., Neu, A., Eichler, R., Jakovcevski, I., Ivanov, A., Hanganu-Opatz, I. L., Bernard, C., Morellini, F., et al. (2015) · Nature Medicine · doi:10.1038/nm.3987 · Cited by 125
Taubes, A., Nova, P., Zalocusky, K. A., Kosti, I., Bicak, M., Zilberter, M. Y., Hao, Y., Yoon, S. Y., Oskotsky, T., Pineda, S., et al. (2021) · Nature Aging · doi:10.1038/s43587-021-00122-7 · Cited by 118
“The two EHR studies were approved by the Institutional Review Board at the UCSF (20-32422) and the Icahn School of Medicine at Mount Sinai (19-02369).”
Method
Metadata
- Authors
- Puskarjov, M., Kahle, K. T., Ruusuvuori, E., & Kaila, K.
- Venue
- Epilepsia
- Publisher
- Wiley
- Published
- 2014-05-06
- Volume
- 55
- Issue
- 6
- Pages
- 806-818
- ISSN
- 0013-9580 (ISSN-L)
- 1528-1167
- OpenAlex
- W2122555934
- Cited by
- 132
- References
- 8
- FWCI
- 9.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.